We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-2.1%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$34.1B
AUM Growth
-$2.63B
(-7.2%)
Cap. Flow
-$362M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
13.14%
Holding
2,315
New
186
Increased
813
Reduced
981
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$283M |
| 2 |
Medtronic
MDT
|
+$96M |
| 3 |
Philip Morris
PM
|
+$80.4M |
| 4 |
United Parcel Service
UPS
|
+$75.5M |
| 5 |
Dominion Energy
D
|
+$74.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$178M |
| 2 |
General Mills
GIS
|
+$158M |
| 3 |
ExxonMobil
XOM
|
+$138M |
| 4 |
ServiceNow
NOW
|
+$96M |
| 5 |
Keysight
KEYS
|
+$72.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.14% |
| 2 | Financials | 15.14% |
| 3 | Technology | 13.55% |
| 4 | Consumer Discretionary | 8.1% |
| 5 | Consumer Staples | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
National Grid
NGG
$75.4B
| $45M | 0.13% |
941,740
+36,069
| +4% | +$2.17M |
|
202
Alliant Energy
LNT
$17.4B
| $44.6M | 0.13% |
840,872
-160,587
| -16% | -$9.69M |
|
203
Trex
TREX
$4.45B
| $43.7M | 0.13% |
995,442
-376,932
| -27% | -$20.2M |
|
|
ALBO
204
DELISTED
Albireo Pharma Inc
ALBO
| $43.7M | 0.13% |
2,258,124
+3,000
| +0.1% | +$62K |
|
|
DEA
205
Easterly Government Properties
DEA
$1.13B
| $43.7M | 0.13% |
1,108,700
+56,776
| +5% | +$2.63M |
|
206
Public Service Enterprise Group
PEG
$36.1B
| $43.6M | 0.13% |
775,021
+478,829
| +162% | +$30.8M |
|
207
American Water Works
AWK
$27.4B
| $43.2M | 0.13% |
331,984
+11,334
| +4% | +$1.71M |
|
|
GTM
208
ZoomInfo Technologies
GTM
$1.22B
| $42.9M | 0.13% |
1,029,633
+2,600
| +0.3% | +$110K |
|
209
IDEAYA Biosciences
IDYA
$3.63B
| $42.7M | 0.13% |
2,862,091
+700,000
| +32% | +$9.09M |
|
210
Inspire Medical Systems
INSP
$2.15B
| $42.6M | 0.12% |
240,000
| – | – |
|
211
Citigroup
C
$228B
| $42.5M | 0.12% |
1,020,801
-260
| -0% | -$12.8K |
|
212
Humana
HUM
$48.9B
| $42.4M | 0.12% |
87,302
+5,513
| +7% | +$2.68M |
|
213
Americold
COLD
$4.17B
| $42.3M | 0.12% |
1,720,500
+206,900
| +14% | +$6.25M |
|
|
AYX
214
DELISTED
Alteryx Inc
AYX
| $41.9M | 0.12% |
750,000
+100,000
| +15% | +$5.86M |
|
215
UGI
UGI
$8.09B
| $41.2M | 0.12% |
1,273,230
+34,718
| +3% | +$1.37M |
|
216
Lam Research
LRCX
$342B
| $41M | 0.12% |
1,120,970
-700,510
| -38% | -$31.2M |
|
|
SCHW
217
Charles Schwab
SCHW
$186B
| $40.9M | 0.12% |
568,557
+558,049
| +5,311% | +$38.7M |
|
|
RNAM
218
DELISTED
Avidity Biosciences
RNAM
| $40.5M | 0.12% |
2,478,000
+3,500
| +0.1% | +$67K |
|
219
Lamar Advertising Co
LAMR
$15.1B
| $40.3M | 0.12% |
489,069
-120,757
| -20% | -$11.5M |
|
|
SPLK
220
DELISTED
Splunk Inc
SPLK
| $39.7M | 0.12% |
527,539
-173,708
| -25% | -$17M |
|
221
Illumina
ILMN
$31.4B
| $39.4M | 0.12% |
212,461
-46,587
| -18% | -$9.22M |
|
222
Yeti Holdings
YETI
$2.94B
| $39.4M | 0.12% |
1,379,803
-499,874
| -27% | -$20.8M |
|
223
Hartford Financial Services
HIG
$36.9B
| $39.1M | 0.11% |
631,013
+149,751
| +31% | +$9.75M |
|
|
ROIC
224
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $39M | 0.11% |
2,834,573
-358,400
| -11% | -$5.91M |
|
|
NVRO
225
DELISTED
NEVRO CORP.
NVRO
| $38.8M | 0.11% |
832,930
-248,871
| -23% | -$11.6M |
|
Similar funds
Federated Hermes's Q3 2022 Portfolio in Review
As of Q3 2022, Federated Hermes held 2,315 positions worth $34.1B, down 7.2% from $36.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q3 2022 filing shows 186 new, 813 increased, 981 reduced and 182 closed positions. Its largest new stake was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M. The largest sale was Cardinal Health, an estimated $178M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- Federated Hermes's largest Q3 2022 buy was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M.
- Federated Hermes added most to JPMorgan Chase in Q3 2022, an estimated $283M increase.
- Federated Hermes's biggest Q3 2022 reduction was Cardinal Health, cutting an estimated $178M.
- Federated Hermes fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $69.1M.
- Federated Hermes's ten largest holdings make up 13% of its $34.1B portfolio in Q3 2022.
- Federated Hermes opened 186 new positions and closed 182 in Q3 2022.
- Federated Hermes's portfolio value fell 7.2% quarter-over-quarter to $34.1B.
Based on Federated Hermes's 13F filing for Q3 2022, filed 14 Nov 2022.